Latest News

International Seaways recently disclosed that Chief Accounting Officer James D. Small III sold 20,000 shares of common stock for roughly US$1.5 million, following a period of strong operational performance and a record quarterly dividend. This sale, the largest proportion of his holdings he has disposed of in a single transaction, comes as the company highlights its best quarter since early 2024, ongoing fleet renewal, lower net loan-to-value, and fresh bond issuance. Next, we’ll examine how...

Infineon Technologies (XTRA:IFX) has joined the AR Alliance, a cross industry group focused on augmented reality hardware development. The move connects Infineon with device makers, component suppliers and software players working on next generation spatial computing and display technologies. The AR Alliance aims to coordinate technical efforts around AR components, system design and interoperability for consumer and industrial uses. For investors, this connects Infineon, a major...

BP (LSE:BP) is reassessing its global supply chain and risk exposure after an escalation in the Iran war. The conflict has effectively closed the Strait of Hormuz, disrupting oil flows and affecting major refineries worldwide. BP’s chief economist has highlighted the scale and likely lasting impact of this disruption on energy markets and corporate risk planning. LSE:BP is a large integrated energy company with operations across oil production, refining, trading, and growing lower carbon...

Setting Up The Valuation Picture For AXIS Capital Holdings AXIS Capital Holdings might be on your radar if you are asking whether the current share price lines up with the underlying value of the business, and this article is built to help you answer exactly that question. At a last close of US$98.91, the stock has seen a 0.7% return over the last 7 days, a 3.6% decline over 30 days, a 5.1% decline year to date, a 1.1% return over 1 year, and very large gains of 93.7% over 3 years and 122.0%...

Fox (FOXA) is back in focus after its streaming platform Tubi announced a broad set of ad tech upgrades, interactive formats and high profile content partnerships at the IAB NewFronts in New York. See our latest analysis for Fox. At a share price of US$59.11, Fox has seen a 9.22% 1 month share price return but a 19.86% share price decline year to date. Its 1 year total shareholder return of 9.03% and 3 year total shareholder return of 80.30% suggest longer term holders have experienced much...

What recent performance says about Plains All American Pipeline Plains All American Pipeline (PAA) has caught investor attention after a 0.4% decline over the past day, alongside gains of 3.6% for the week and about 9.7% over the past month. Those moves sit on top of a roughly 27.1% return over the past 3 months and about 23.2% year to date. The units closed at US$22.44, with a market value near US$15.9b. See our latest analysis for Plains All American Pipeline. For PAA, the recent 1 month...

Rogers (NYSE:ROG) recently reported that annual sales have declined by 5.5% for two consecutive years, while rising costs have reduced its operating margin by 7.2 percentage points, pressuring profitability across its engineered materials portfolio. This combination of falling revenue and shrinking margins has raised concerns that the company’s products are not fully aligning with current demand in electric vehicles, telecommunications, and other high‑performance applications. We’ll now...

Why Carlsberg (CPSE:CARL B) is on investors’ radar Carlsberg (CPSE:CARL B) has drawn attention after a one‑month return of an 18% decline, alongside a past three‑month drop of 3.2%, prompting investors to reassess the brewer’s valuation and financial profile. See our latest analysis for Carlsberg. At a share price of DKK796.6, Carlsberg’s recent 18% one month share price decline sits alongside a 3.5% year to date share price fall and a 7.3% one year total shareholder return decline, pointing...

On March 20, 2026, JPMorgan upgraded Air Products and Chemicals to Overweight, citing the company’s resilient earnings profile despite macroeconomic pressures and benefits from tightening helium supply. The upgrade also underscored how rising helium prices, driven by geopolitical supply constraints, could support Air Products’ gas portfolio alongside its refinery-linked businesses. We’ll now examine how JPMorgan’s helium-focused rationale fits with Air Products’ existing investment narrative...

For readers wondering whether AAR at US$107.25 is still priced fairly after a strong run, or if the value case is already reflected in the price, this article walks through the numbers so you can assess the valuation with more confidence. The stock shows a mixed short-term picture, with a 5.8% return over the past week, an 8.4% decline over the last 30 days, a 27.0% year-to-date return, and an 87.7% return over the past year. Those moves sit against a longer backdrop in which the shares have...

GXO Logistics (GXO) is back in focus after opening Hasbro’s 600,000 square foot, AI powered distribution center in Midway, Georgia, and rolling out an autonomous industrial truck pilot in France. See our latest analysis for GXO Logistics. Even with headlines around AI powered warehouses and autonomous trucks, GXO’s share price has had a 22.18% decline over the past month and an 8.58% year to date share price decline. The 1 year total shareholder return is 26.25%, which hints that longer term...

Veritone (VERI) has drawn fresh attention after announcing a multi-year agreement with Oracle to move its AI solutions, including aiWARE, Veritone Data Refinery, and Veritone Data Marketplace, onto Oracle Cloud Infrastructure. See our latest analysis for Veritone. The Oracle agreement and recent product updates arrive after a steep reset in expectations, with the share price down 61.6% year to date and a 5 year total shareholder return decline of 92.5%, pointing to fading momentum as...

Reddit (RDDT) is back in focus after a Los Angeles jury held Meta and Alphabet liable for social media addiction harms, a ruling that has sharpened investor attention on Reddit’s potential legal and regulatory exposure. See our latest analysis for Reddit. At a share price of $121.84, Reddit has seen a 1 day share price return of 4.26% decline and a 90 day share price return of 46.03% decline, even as the 1 year total shareholder return sits at 13.12%. Recent legal headlines and executive...

Automatic Data Processing (ADP) is back in focus after its ADP Research arm released the Today at Work 2026, Issue 1 report, which highlights widespread worker anxiety about job security as employers adopt AI and adjust to demographic change. See our latest analysis for Automatic Data Processing. Despite spotlight-grabbing research on AI and worker anxiety and an upcoming quarterly earnings release on April 29, the share price has lost momentum. The 90-day share price return of 22.25% and the...

Anthropic is reportedly testing a new Claude Mythos AI model with advanced cybersecurity and reasoning abilities that could challenge traditional platforms. Leaked documents suggest Claude Mythos may offer AI native defense and offense tools that change how enterprises detect and respond to cyber threats. These reports arrive as investors reassess exposure to established cybersecurity vendors such as Palo Alto Networks, ticker NasdaqGS:PANW. Palo Alto Networks enters this news cycle with a...

Ag Growth International (TSX:AFN) has launched a broad overhaul of its business, including executive cuts, North American reorganization, cost actions, and an immediate suspension of its quarterly dividend following recent leadership changes. See our latest analysis for Ag Growth International. The share price closed at CA$17.99 after the announcement, with a 7 day share price return of 24.79% decline and a 30 day share price return of 36.72% decline. The 1 year total shareholder return of...

Cloudia Research S.p.A. ( BIT:AGAIN ), might not be a large cap stock, but it received a lot of attention from a...

Shareholder John Chevedden has filed a proposal at Dover Corporation (NYSE: DOV) calling for an independent board chairman. The proposal seeks a formal policy that the roles of Chairman and CEO be held by different individuals. Dover's board has recommended that shareholders vote against the proposal at the upcoming annual general meeting. Dover, traded on the NYSE under the ticker DOV, operates as a diversified industrial company with exposure to equipment, components, and related...

ANI Pharmaceuticals recently reported record 2025 revenue of US$883.4 million, driven largely by strong growth in its Rare Disease segment and Cortrophin Gel, while an executive share sale on March 11, 2026 drew investor attention. The company’s guidance for more than US$1.00 billion in 2026 revenue highlights how Rare Disease therapies are becoming an increasingly central pillar of its business model. We’ll now examine how ANI Pharmaceuticals’ push past US$1.00 billion in guided 2026...

Attention around Oscar Health (OSCR) is building ahead of its forthcoming earnings release, where projections point to a significantly higher EPS than a year ago, set alongside expanding margins and rising operational efficiency. See our latest analysis for Oscar Health. Despite the upcoming earnings focus, recent trading has been weak, with a 30 day share price return showing a decline of 13.98% and a year to date share price return showing a decline of 25.58%, while the 3 year total...

Investors in Puuilo Oyj ( HEL:PUUILO ) had a good week, as its shares rose 5.9% to close at €12.36 following the...

Pihlajalinna Oyj ( HEL:PIHLIS ) is about to trade ex-dividend in the next three days. The ex-dividend date is usually...

In March 2026, Constellation Energy filed a definitive proxy urging shareholders to vote against a DEI-related proposal and registered up to 50,000,000 common shares, worth about US$15.86 billion, for an ESOP-related shelf offering. These moves come as Constellation deepens nuclear-focused partnerships with major technology companies and reshapes its generation portfolio following the Calpine acquisition and planned PJM asset sales. We’ll now examine how Constellation’s expanded nuclear...

SELLAS Life Sciences Group (SLS) is drawing attention after releasing preclinical data on its CDK9 inhibitor SLS009 in acute myeloid leukemia and filing both a universal shelf registration and a US$150 million at-the-market equity offering. See our latest analysis for SELLAS Life Sciences Group. Those preclinical SLS009 data and the fresh shelf and at the market filing are landing after a sharp run, with the 1 year total shareholder return near 3x and a 52.09% 90 day share price return, even...